Hook & thesis
Zoom Communications ($107.43) looks inexpensive relative to its cash generation and optionality. The core collaboration business is stable, profitable, and producing nearly $2.0B of free cash flow annually. On top of that, Zoom carries a roughly $1.27B equity position in Anthropic — a hidden asset that could reprice the shares if Anthropic IPO chatter or strategic monetization accelerates around the company’s Q2 release.
My trade: take a mid-term long ahead of Q2 earnings. The numbers imply reasonable downside and meaningful upside if management signals improving enterprise traction, better-than-expected guidance, or any Anthropic-related valuation event. Technicals and low days-to-cover make this a pragmatic trade with clearly defined risk/reward.
What Zoom does and why investors should care
Zoom is a communications and collaboration platform operating across Americas, APAC, and EMEA. The product remains sticky with enterprises and SMEs that value reliable video, meetings, and an expanding set of AI-assisted collaboration features. Management has continued to invest in AI capabilities and international expansion, most recently elevating a senior APAC executive to scale growth across Asia and Australia.
The market cares for two reasons: 1) Zoom is a cash-generative SaaS name in a market that often values recurring revenue well, and 2) it holds a material, non-core equity position in Anthropic that acts like a latent call option on a large AI franchise. That combination is rare: stable core business plus a convex external AI upside.
Key fundamentals and valuation snapshot
| Metric | Value |
|---|---|
| Share price | $107.43 |
| Market cap | $31.5B |
| Enterprise value | $30.61B |
| Free cash flow (annual) | $1.96B |
| EPS (trailing) | $7.06 |
| Price / Earnings | ~15x |
| Price / FCF | ~16x |
| EV / EBITDA | ~23x |
| 52-week range | $70.70 - $114.74 |
At a $31.5B market cap and nearly $2.0B in free cash flow, Zoom trades around mid-teens on P/FCF and P/E. For a profitable SaaS company with stable retention and clear cost discipline, mid-teens is not expensive. If the market starts to reassign a premium for AI-enabled differentiation or recognizes the Anthropic stake explicitly, multiple expansion is plausible.
Why the market might re-rate Zoom now
- Hidden Anthropic optionality - Zoom holds a meaningful equity position in Anthropic (reported at roughly $1.27B cost but valued at north of $3B in some coverage), giving Zoom indirect exposure to a high-growth AI native developer. Any public market movement for Anthropic — IPO filing details, pricing, or partner-led monetization — could show up as incremental valuation for Zoom.
- Q2 earnings setup - Earnings present an information event. Beat-and-raise on revenue or guidance — or incremental color on Anthropic exposure, product integrations, or international traction — would be the straightforward re-rating trigger.
- Healthy cash generation - Nearly $2.0B in FCF provides optionality: buybacks, bolt-on M&A, or strategic returns tied to the Anthropic stake’s value.
- Technical backdrop - Momentum indicators are constructive (RSI ~63, bullish MACD), average volumes are supportive, and short interest is modest (days-to-cover ~2.3). That makes upside moves less likely to be choked by heavy short squeezes and more likely to attract buyers on positive news.
Catalysts (2-5)
- Q2 earnings call - Any upgrade to guidance or accelerating enterprise ARR expansion will be the immediate catalyst.
- Anthropic news flow - IPO pricing, valuation disclosures, or a sale/partial monetization of the stake would be a direct re-rate.
- APAC execution - Early signs that the newly consolidated APAC leadership is lifting growth in high-opportunity markets.
- Share-repurchase or capital returns tied to the Anthropic holding - management framing capital allocation around monetizing or leveraging the stake.
Trade plan (actionable)
Idea: Long Zoom ahead of Q2 earnings aiming for multiple expansion or Anthropic-related rerating.
- Entry price: $107.43
- Stop loss: $98.00
- Target price: $132.00
- Trade direction: Long
- Horizon: mid term (45 trading days) - the goal is to capture post-earnings repricing and any near-term Anthropic-related news while limiting exposure to longer economic cycles.
Rationale: Entry at $107.43 leaves room for upside to $132 driven by multiple expansion from ~15x P/E toward the high-teens or low-20s if investors price in the Anthropic optionality. Stop at $98 limits downside in case of a bearish beat-and-guide or any short-term execution miss; the stop sits below near-term moving averages and gives the trade room to breathe while protecting capital.
Valuation framing - why this looks cheap
Zoom's trailing EPS of $7.06 and a P/E of ~15 implies the market is not paying a premium for significant growth; instead it is valuing Zoom as a steady, cash-generative business. With $1.96B of free cash flow and an enterprise value near $30.6B, the implied EV/FCF sits in the mid-teens — reasonable for a profitable SaaS name with product-led growth and AI differentiation. If the market assigns even modest optionality value to the Anthropic stake or grants a premium for accelerating AI features that drive upsell, multiples can re-rate meaningfully from here.
Risks and counterarguments
- Execution risk on core product - If Zoom's enterprise expansion stalls or churn creeps higher, the business would justify a lower multiple. A disappointing metric set on the Q2 call would likely push shares below the stop.
- Anthropic monetization uncertainty - The Anthropic stake is optionality, not guaranteed value. If Anthropic delays an IPO or is valued lower than market headlines suggest, that upside may never materialize.
- Macro and multiple compression - A broader risk-off in tech or a rotation away from SaaS could compress multiples across the sector, negating company-specific positives despite stable cash flow.
- Insider selling optics - Recent CEO sales (executed under a 10b5-1 plan) can be misread by the market and produce negative sentiment even if they are routine. Expect noisy headlines around executive transactions.
- Counterargument: The market already prices in the Anthropic stake - critics will say any Anthropic value is already reflected and that Zoom's organic growth profile doesn't justify a significant re-rate. That is plausible; the thesis requires either confirmation of Anthropic valuation upside or a clear beat-and-guide to unlock the multiple. If neither appears, the stock can remain rangebound or drift lower.
What would change my mind
I will rethink this trade if one or more of the following happen: 1) Q2 results show a sustained deterioration in ARR growth or materially higher churn, 2) Anthropic explicitly disavows any near-term liquidity event or its valuation narrative weakens materially, or 3) management pivots capital allocation to dilutive M&A that impairs free cash flow conversion. Conversely, visible steps to monetize the Anthropic position, a stronger-than-expected guide, or accelerating APAC adoption would reinforce the bullish stance.
Bottom line
Zoom is a practical, mid-cap SaaS name with real cash generation and a concrete, high-conviction optionality via Anthropic. At $107.43 the company looks reasonably priced and presents a tradeable asymmetric opportunity around Q2 results. The plan above sets clear entry, stop, and target levels with a defined mid-term horizon of 45 trading days — enough time for the earnings event and any related Anthropic or strategy updates to play out.
Trade idea summary: Long ZM at $107.43, stop $98.00, target $132.00, mid term (45 trading days). Keep position size modest and respect the stop — the thesis is event-driven and depends on either company execution or Anthropic-related revaluation.